Among them, FBLN1 and FBLN2 (fibulin 2) were found to be downregulated and acted as tumour suppressive genes in certain cancers such as prostate cancer and breast cancer (Wlazlinski et al, 2007; Yi et al, 2007). Here, FBLN2 is linked to prostate cancer.